Ascendis Pharma
ASND
ASND
147 hedge funds and large institutions have $5.45B invested in Ascendis Pharma in 2020 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 44 increasing their positions, 58 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $6.42B → $5.45B (-$969M)
24% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 58
33% less funds holding in top 10
Funds holding in top 10: 15 → 10 (-5)
Holders
147
Holding in Top 10
10
Calls
$50.7M
Puts
$21.8M
Top Buyers
| 1 | +$226M | |
| 2 | +$82.2M | |
| 3 | +$69.2M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$45.4M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$44.5M |
Top Sellers
| 1 | -$64M | |
| 2 | -$32.7M | |
| 3 | -$24.6M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$19.7M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$16.9M |